Inoviv develops proteomics-based biomarker tests to support pharmaceutical companies in running clinical trials.

Edit ID  10311680 

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 30 Mar 2019 1:11 am
Edits made to:
Article (+17/-17 characters)


Inoviv’s services include Patient Identification and Stratification, Companion Diagnostics and Treatment Efficacy Monitoring. The company measures more than 50 calibrating molecules per biofluid sample and analyzes 3000 biofluid/tissue samples per day. Their technology uses mass spectrometry-based targeted proteomics to test multiplexed protein, peptide, lipid and metabolite biomarker panels. Mass spectrometryMass spectrometry measures the mass-to-charge ratio of molecules. Inoviv’s uses a triple quadrupole mass spectrometry system.